Molecular Diagnostics
Haptoglobin Genotyping Test Enables Key Diabetes Treatment
A breakthrough ELISA kit, based on the Haptoglobin 2-2 (Hp 2-2) protein marker, can identify diabetes patients at higher risk of developing lethal cardiovascular disease or renal failure, thereby enabling them to take Vitamin E, a nutritional supplement shown to be of great benefit to them but posing harm to the remaining non HP 2-2 diabetic population. A CE mark application for the test is currently in progress, with FDA certification planned for the US market. More...29 May 2017
Recurrent Mutation Linked to Childhood Blindness
Researchers have identified a genetic mutation that contributes to the sight loss that occurs in children with ocular coloboma, a developmental defect that causes part of the eye to be missing at birth. The findings shed light on its causes and help explain how genes contribute to development of the eye. More...29 May 2017
Alzheimer’s Disease Progression Predicted by Gene Mutation
Alzheimer's disease is the most common form of dementia in older adults. It is a degenerative condition, characterized by a steady loss of memory and a reduced ability to carry out daily activities. Today, an estimated five million people in the USA are living with the disease. More...25 May 2017
Gene Sequencing Reveals Mutations in Endometriosis
Endometriosis occurs when tissue lining the uterus forms and grows outside of the organ, most often into the abdomen. The disease occurs in up to 10% of women before menopause and half of those with abdominal pain and infertility problems. More...24 May 2017
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Automated MALDI-TOF MS System
EXS 3000
In Other News
Molecular Test Predicts Blood Cancer Patient Survival
Solvent Interaction Analysis of PSA Reduces Need for Biopsies
Elevated Levels of Beta-2 Microglobulin Linked to Increased Stroke Risk
Low Levels of Protein Linked to Cognitive Decline
Test Predicts Benefit of Targeted Cancer Treatments
Genomic Duplication Responsible for Rare Skin Disease
Typhoid Fever Victims Present Unique Metabolomic Profile
Child Biomarkers Linked to BD Parents
Immune Response Differentiates Malaria from Other Infections
POC Test Advances Hepatitis C Diagnosis
Genes Should Be Screened for Stem Cell Transplants
Genetics Are Key to Lowering Bone Fracture Risk
Novel Fluorescent Technique Detects Early Stage Glaucoma
Low Levels of 1-Asparaginase Predict Cancer Recurrence
Multigene Test Extends Life Expectancy for Cancer Patients
Bordetella Direct Test Receives FDA Clearance
Bacterial Pathogens Panel Receives CE Marking
Methods Assessed for Detecting Asymptomatic Malaria
Newborn Screening for CMV Remains Controversial
Multiplex Molecular Assays for Respiratory Viruses Evaluated
Panel of Gut Bacteria Diagnostic for Colorectal Cancer
LAMP-based Assay Launched for Detection of Malaria
Rapid Assay Identifies Genetic Mutations Associated with NSCLC
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.